Gamma-Aminobutyric Acid Type A Receptor Subunit Pi is a potential chemoresistance regulator in colorectal cancer.

Tengyu Wang Qinghao Zhen Tong Wu Lan Jin Surui Yao Yuyang Feng Jinghua Chen Chen Chen Zhaohui Huang

Published in: Molecular biology reports (2023)

We identify GABRP as a promising drug target to mediate oxaliplatin or 5-FU resistance in CRC. It provided the theoretical basis and potential clinical value for CRC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
human health
transcription factor
risk assessment
climate change
cancer stem cells